GX-I7, a long-acting IL-7, safely and effectively increased peripheral CD8+/CD4+ T cells and TILs in patients with locally advanced or metastatic solid tumours.

Saved in:
Bibliographic Details
Title: GX-I7, a long-acting IL-7, safely and effectively increased peripheral CD8+/CD4+ T cells and TILs in patients with locally advanced or metastatic solid tumours.
Authors: Kim GM; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea., Kim S; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea.; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea., Lee MA; Division of Medical Oncology, Seoul St, Mary's Hospital, The catholic University of Korea, Seoul, Korea., Byun MS; Genexine, Inc., Seoul, Korea., Choi D; NeoImmuneTech, Inc., Rockville, MD, USA., Yang SH; NeoImmuneTech, Inc., Rockville, MD, USA., Woo J; Genexine, Inc., Seoul, Korea., Sung YC; Genexine, Inc., Seoul, Korea., Shin EC; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea., Park SH; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea. park3@kaist.ac.kr., Kim TW; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. twkimmd@amc.seoul.kr., Sohn J; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea. ONCOSOHN@yuhs.ac.
Source: British journal of cancer [Br J Cancer] 2025 Sep; Vol. 133 (4), pp. 524-532. Date of Electronic Publication: 2025 Jun 09.
Publication Type: Journal Article; Clinical Trial, Phase I; Multicenter Study
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first